| scholarly article | Q13442814 |
| P50 | author | Edward G. Lakatta | Q32985045 |
| P2093 | author name string | Jing Zhang | |
| James Wu | |||
| Mark Talan | |||
| Mingyi Wang | |||
| Kapil Kapoor | |||
| Liqun Jiang | |||
| Richard Telljohann | |||
| Robert E Monticone | |||
| P2860 | cites work | Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries | Q23909575 |
| Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors | Q28369255 | ||
| Role of angiotensin II and endothelin-1 receptors in aging-related functional changes in rat cardiovascular system | Q28569276 | ||
| Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function | Q28582388 | ||
| Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling | Q28610876 | ||
| Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification | Q30474772 | ||
| Increased aortic calpain-1 activity mediates age-associated angiotensin II signaling of vascular smooth muscle cells | Q30843714 | ||
| Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells | Q33216082 | ||
| Phenotypic overlap between MMP-13 and the plasminogen activation system during wound healing in mice | Q33822269 | ||
| A local proinflammatory signalling loop facilitates adverse age-associated arterial remodeling | Q33828844 | ||
| Involvement of NADPH oxidase in age-associated cardiac remodeling | Q33882656 | ||
| Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study | Q74694126 | ||
| Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload | Q78068456 | ||
| Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR | Q80101196 | ||
| Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men | Q82810771 | ||
| Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling | Q33930863 | ||
| Arterial aging: a journey into subclinical arterial disease | Q34144269 | ||
| Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels | Q34144489 | ||
| Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors | Q34389230 | ||
| Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. | Q34542211 | ||
| Central Arterial Aging and Angiotensin II Signaling | Q34681004 | ||
| Treatment of hypertension in patients 80 years of age or older | Q34766135 | ||
| Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with aging | Q34981297 | ||
| Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats | Q35085406 | ||
| Matrix metalloproteinase inhibitor development and the remodeling of drug discovery | Q35636536 | ||
| Linkage of cardiac gene expression profiles and ETS2 with lifespan variability in rats | Q35836377 | ||
| Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation | Q35861493 | ||
| The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors | Q36368334 | ||
| A Dominant Negative Inhibitor Indicates that Monocyte Chemoattractant Protein 1 Functions as a Dimer | Q36554378 | ||
| Regulation of vascular inflammation and remodeling by ETS factors | Q36661332 | ||
| Inhibiting metalloproteases with PD 166793 in heart failure: impact on cardiac remodeling and beyond. | Q37157939 | ||
| The role of p66Shc deletion in age-associated arterial dysfunction and disease states. | Q37261119 | ||
| Milk fat globule protein epidermal growth factor-8: a pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion | Q37394615 | ||
| Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix. | Q40159420 | ||
| Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase | Q41646524 | ||
| Arterial stiffening with ageing is associated with transforming growth factor-β1-related changes in adventitial collagen: reversal by aerobic exercise | Q42921061 | ||
| Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte. | Q43064761 | ||
| Initial characterization of a neutral metalloproteinase, active on native 3/4-collagen fragments, synthesized by ROS 17/2.8 osteoblastic cells, periodontal fibroblasts, and identified in gingival crevicular fluid | Q43653461 | ||
| Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats | Q43820840 | ||
| Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study | Q44234203 | ||
| Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates | Q44438499 | ||
| Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade | Q46644752 | ||
| Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging. | Q54479601 | ||
| Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent | Q55216617 | ||
| Combination of Tumor Necrosis Factor-α Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice | Q58211733 | ||
| Myocardial Infarct Expansion and Matrix Metalloproteinase Inhibition | Q59651627 | ||
| Proinflammatory Profile Within the Grossly Normal Aged Human Aortic Wall | Q63245414 | ||
| Matrix Metalloproteinase 2 Activation of Transforming Growth Factor-β1 (TGF-β1) and TGF-β1–Type II Receptor Signaling Within the Aged Arterial Wall | Q63245415 | ||
| Identification of protease(s) capable of further degrading native 3/4- and 1/4-collagen fragments generated by collagenase from native type I collagen in human neutrophils | Q69350776 | ||
| Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries | Q72101596 | ||
| Aerobic exercise training reduces plasma endothelin-1 concentration in older women | Q73066960 | ||
| Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor | Q73175870 | ||
| Matrix Metalloproteinase-3 Genotype Contributes to Age-Related Aortic Stiffening Through Modulation of Gene and Protein Expression | Q73400898 | ||
| Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats | Q73699573 | ||
| Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure | Q73850307 | ||
| Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells | Q74254758 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 459-66 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure | |
| P478 | volume | 60 |
| Q64065531 | 4-Hexylresorcinol and silk sericin increase the expression of vascular endothelial growth factor via different pathways |
| Q34392563 | A heart that beats for 500 years: age-related changes in cardiac proteasome activity, oxidative protein damage and expression of heat shock proteins, inflammatory factors, and mitochondrial complexes in Arctica islandica, the longest-living noncolon |
| Q28080582 | Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries |
| Q41880235 | Age-related Impairment of Vascular Structure and Functions |
| Q34891104 | Aging, arterial stiffness, and hypertension |
| Q33777499 | Arterial stiffness and hypertension |
| Q50097038 | Arterial stiffness as a risk factor for clinical hypertension |
| Q87206709 | Ascending Aorta Elastography After Kawasaki Disease Compared to Systemic Hypertension |
| Q91708876 | Association of pulse pressure with all-cause and cause-specific mortality |
| Q93217182 | Association of triglycerides to high-density lipoprotein-cholesterol ratio with risk of incident hypertension |
| Q58127004 | Calorie Restriction Curbs Proinflammation That Accompanies Arterial Aging, Preserving a Youthful Phenotype |
| Q35598638 | Can proteomics yield insight into aging aorta? |
| Q38906962 | Exercise training reverses age-induced diastolic dysfunction and restores coronary microvascular function |
| Q91586511 | Habitual aerobic exercise and circulating proteomic patterns in healthy adults: relation to indicators of healthspan |
| Q38544227 | Hypertension, Diabetes Type II, and Their Association: Role of Arterial Stiffness |
| Q56961974 | Innate and adaptive immunity in atherosclerosis |
| Q48114716 | Is cardiovascular disease in patients with diabetes associated with serum levels of MMP-2, LOX, and the elastin degradation products ELM and ELM-2? |
| Q37638807 | Is increased arterial stiffness a cause or consequence of atherosclerosis? |
| Q93018511 | MFG-E8 mediates arterial aging by promoting the proinflammatory phenotype of vascular smooth muscle cells |
| Q36910638 | Matrix metalloproteinases as drug targets in preeclampsia |
| Q35175533 | Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis |
| Q91251169 | Nrf2 in aging - Focus on the cardiovascular system |
| Q92850623 | Oxidative stress and vascular stiffness in hypertension: A renewed interest for antioxidant therapies? |
| Q36328478 | Pharmacogenomics study on cadherin 2 network with regard to HIV infection and methadone treatment outcome |
| Q27015975 | Proinflammation of aging central arteries: a mini-review |
| Q28395632 | Proinflammation: the key to arterial aging |
| Q90715489 | Proinflammatory Arterial Stiffness Syndrome: A Signature of Large Arterial Aging |
| Q55365578 | Reduced vasorin enhances angiotensin II signaling within the aging arterial wall. |
| Q49993782 | Role of Thioredoxin in Age-Related Hypertension |
| Q37209809 | Serum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 Diabetes |
| Q50133565 | Strategies for Achieving Healthy Vascular Aging |
| Q37219786 | Testosterone delays vascular smooth muscle cell senescence and inhibits collagen synthesis via the Gas6/Axl signaling pathway |
| Q30240720 | The Pressure of Aging |
| Q35043161 | The Reality of Aging Viewed from the Arterial Wall: An Interview with Dr. Edward Lakatta, Founder and Director of the Laboratory of Cardiovascular Science, National Institute on Aging |
| Q38838486 | The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications |
| Q36823269 | The reality of aging viewed from the arterial wall |
| Q38664083 | Toll-like receptor-4 signaling pathway in aorta aging and diseases: "its double nature". |
| Q38204490 | Transcriptomic network support distinct roles of classical and non-classical monocytes in human. |
| Q38671493 | Vascular Calcification in Uremia: New-Age Concepts about an Old-Age Problem |
| Q26749488 | Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications |
Search more.